CTP-543 | Friends of Cancer Research

You are here

CTP-543

Sponsor: 
Concert Pharmaceuticals
Indication: 
Treatment of Alopecia Areata
Year: 
2020
Date: 
Jul 8th
FDA Status: 
Designation Granted